archiveParticipate

SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will participate in the following upcoming healthcare conferences: Investment ConferencesJefferies Global Healthcare Conference (New York)   Presentation Thursday, June 5, 9:20 AM ET + 1x1 meetingsSachs European BioPharma Obesity Innovation Forum   Next Gen Therapeutics Panel + presentation + 1x1 meetings, Wednesday, June 11 Get the latest news delivered to your inbox Sign up for...